Infectious Diseases News and Research

RSS
Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Traditional Japanese dish may hold an answer to COVID-19

Traditional Japanese dish may hold an answer to COVID-19

Older people appear to have diminished antibody response after COVID-19 vaccination

Older people appear to have diminished antibody response after COVID-19 vaccination

Existing drug may be effective in treating COVID-19

Existing drug may be effective in treating COVID-19

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

Scientists explore susceptibility of different animals to SARS-CoV-2 infection

Scientists explore susceptibility of different animals to SARS-CoV-2 infection

APPC survey: Public trust in top U.S. health agencies and Fauci holds steady

APPC survey: Public trust in top U.S. health agencies and Fauci holds steady

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

COVID-19 first wave increased the sale of antibiotic formulations in India

COVID-19 first wave increased the sale of antibiotic formulations in India

A novel method developed for producing new antibiotics to combat resistant bacteria

A novel method developed for producing new antibiotics to combat resistant bacteria

Survival for babies born with congenital anomalies depends on place of birth

Survival for babies born with congenital anomalies depends on place of birth

Study illuminates an invisible crisis in children’s mental health

Study illuminates an invisible crisis in children’s mental health

SARS-CoV-2 B.1.617 mutations L452 and E484Q do not work together to evade antibodies

SARS-CoV-2 B.1.617 mutations L452 and E484Q do not work together to evade antibodies

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants